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The CydDC family of ABC transporters export the low molecular weight thiols glutathione 
and cysteine to the periplasm of a variety of bacterial species. The CydDC complex has 
previously been shown to be important for disulfide folding, motility, respiration, and 
tolerance to nitric oxide and antibiotics. In addition, CydDC is thus far unique amongst ABC 
transporters in that it binds a haem cofactor that appears to modulate ATPase activity. 
CydDC has a diverse impact upon bacterial metabolism, growth, and virulence, and is of 
interest to those working on membrane transport mechanisms, redox biology, aerobic 
respiration, and stress sensing/tolerance during infection. 
 
2. Regulation and assembly of the ABC transporter CydDC 
 
2.1 Identification and cloning of the cydDC genes 
By the early 1990s, the group of Bob Gennis had established by classical genetic techniques 
the presence and location on the E. coli chromosome of two structural genes encoding the 
cytochrome bd-type terminal oxidase [1], now often referred to as cytochrome bd-I following 
the discovery of a second bd-type oxidase in E. coli [2]. The bd-I encoding genes were named 
cydA and cydB, constituting an operon at 16.6 min (physical map position 785-788 bp [3]) on 
the chromosomal map. It is important to note that for many years the cytochrome bd-I 
complex was considered to be a two-subunit complex, but later sequencing studies and the 
crystal structure reveal a third small subunit [4]. A further gene, cydC
+
, annotated as involved 
in ‘cytochrome d assembly’ was also identified, remote from the cydAB locus at 19.2 min 
(938-943 bp) [5]. In brief, a strain lacking cytochrome bo′ was mutagenized and screened for 
mutants incapable of aerobic growth on non-fermentable substrates, other than those with 
mutations in cydAB. The strain (CG03) was used to map the newly identified gene, first by F-
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prime conjugation and then by P1 co-transductions. Reintroducing cyo genes on an F-prime 
episome carrying the cydAB operon failed to complement a cytochrome bd-I-deficient 
mutant, suggesting a new locus. The mutant showed no visible absorbance bands attributable 
to cytochrome bd-I but the spectrum was returned to wild-type characteristics by introducing 
cydC
+
 on an episome. Importantly, in vitro transcription/translation experiments and Western 
immunoblotting of cydC strain membranes showed the CydA and CydB subunits to be 
diminished in cydC membranes compared to the isogenic cydC
+
 strain [5]. Expression from a 
multicopy plasmid of the oxidase subunits in a cydC strain demonstrated that the b595 and b558 
haems were over-produced but the haem d component was absent. This led to the hypothesis 
that a likely role for CydC was biosynthesis of haem d and that, in the absence of this haem, 
the oxidase subunits are destabilised and therefore largely absent [5]. 
The cydC gene was independently described by Siegele et al. and named surB, its 
product being required for E. coli cells to exit (i.e. survive) stationary phase at 37 
o
C under 
aerobic conditions [6]. It was established that the severe temperature-sensitive defect in 
exiting stationary phase of surB1 mutants is due to the absence of terminal cytochrome 
oxidase activity and specifically to the presence of a defective cytochrome bd-I oxidase [7, 
8]. 
 Shortly after, we described a fourth cyd locus identified by an entirely different 
strategy. Allan Downie had screened survivors of nitrosoguanidine mutagenesis for loss of 
spectroscopically detectable cytochrome bd-I using the laborious method of individually 
examining colonies for the 630 nm band of cytochrome d in a Keilin-type hand spectroscope 
at 77 K. The mutation in one such mutant was mapped genetically and shown to be highly co-
transducible with aroA near 20 min on the E. coli chromosome [9]. Further mapping by F-
primes, co-transduction data and three-point crosses clearly established the following gene 
order: poxB – (zbj::Tn10) – cydC – cydD at 19.3 min. Furthermore, a gene implicated in the 
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ability to survive at elevated temperatures, htrD, was shown to be closely linked to cydC and 
cydD [10] and was later shown to be identical to cydD after correction for a missing G in the 
Delaney sequence [11].  
Resulting from this work was a useful selective medium, incorporating zinc and azide 









 genes using a cosmid library and subsequent sub-cloning to give 
plasmids capable of complementing cydC and cydD mutants [12], demonstrating their joint 
presence on plasmids pRP33 and pRP39; restriction maps showed that the cloned fragment of 
the latter lies within the 19 min region of the Kohara map, consistent with earlier P1 mapping 
[9]. In vivo protein synthesis using these plasmids as templates demonstrated the formation of 
CydD and CydC with estimated molecular masses of 61 kDa and 59 kDa, respectively [12], 
whereas the actual molecular weights calculated from the primary sequences (Section 2.2) are 
65 kDa, and 63 kDa, respectively. 
The complete nucleotide sequence of the insert was obtained by manual Sanger 
sequencing [12]. The deduced amino acid sequences of CydD and CydC have 50% similarity 
and 27% identity. Hydropathy profiles showed both to be similar membrane proteins, the N-
terminal halves each forming six transmembrane helices. As detailed below, the C-terminal 
hydrophilic portions each contain an ATP-binding site. Thus CydDC was identified as the 
first known example of a bacterial heterodimeric ABC transporter. The structurally analogous 
HlyB protein, involved in export of haemolysin from E. coli, is a homodimer [13]. 
   Note that in certain bacteria the cydDC and cydAB genes are not well separated on the 
genome, as described here in E. coli, but are found as a single operon and expressed as a 
single transcript, as in Bacillus subtilis [14]. Furthermore, certain bacteria have oxidases 
resembling cytochrome bd-I at the level of gene sequence yet have no spectrally detectable 
haem d. It is therefore interesting to consider possible CydDC proteins in such cases. For 
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example, in Campylobacter jejuni, two genes (cj0081, cj0082), encoding proteins similar to 
those of the CydAB complex in E. coli, were identified from genome sequences [15]. 
However, spectroscopic studies of this oxidase, named CioAB (for cyanide-insensitive 
oxidase) [16], showed that the high-spin haems b558, b595 and the d-type haem, which are 
typical of bd-type oxidases, could not be detected in C. jejuni, suggesting that the enzyme 
was distinct. Furthermore, there are no obvious homologues of cydDC in C. jejuni. Although 
we cannot exclude the possibility of another ABC type transporter fulfilling CydDC 
functions, the apparent correlation between the lack of cytochrome d and a cognate ABC 
transporter is intriguing. Note that C. jejuni does not synthesise glutathione, an identified 
substrate of the E. coli CydDC system (Section 3.1). Other bacteria such as P. aeruginosa 
also possess a bd-type oxidase that lack the characteristic spectral features associated with the 
bd haems [17], and these constitute the CioAB (cyanide-insensitive oxidase) or “short Q-
loop” sub-family [18]. 
  Neither cydD nor cydC are essential genes as evidenced by the manners in 
which the mutants described above were isolated and used. Curiously, Eng et al. [19] 
describe E. coli cydC as an essential gene, without apparent justification, and, interestingly, a 
specific point mutation in an aspartic acid residue at the cytoplasm/membrane interface on 
helix II (cydC-D86V) restored production of a jet-fuel candidate, D-limonene. This study also 
suggested that cytochrome bd-I (i.e. CydABX) and CydDC do not always co-occur: 
computational analyses using the MicrobesOnline server [20] on 1965 genomes showed that 
highly conserved cydC genes are found in 407 species, but only 53 of these species also 
contained a cydB homologue. The presence of CydDC genes in so many genomes that do not 
encode cytochrome bd-I is surprising,  especially since an earlier study by Kranz and 
coworkers did not detect any species that encoded CydDC but lacked cytochrome bd-I (from 
33 bacterial genomes analysed) [21]. Furthermore, Kranz et al. highlighted six species that 
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encode cytochrome bd-I but not CydDC: Rickettsia prowazekii, Chlamidia tracomatis, 
Campylobacter jejuni, Porphyromonas ginigivalis, Aquifex aeolicus, and Thermotoga 
maritima: all of these species were reported to lack both CydDC and cytochrome bd-I in Eng 
et al. [19]. This suggests an issue with detection of cytochrome bd-I homologues in the 
genomics analysis by Eng et al., which is supported by the observation that none of the 
Geobacillus nor Mycobacterium species were found by Eng et al. to encode cytochrome bd-I, 
yet several papers report functional/structural studies on cytochrome bd-I from these 
organisms [4, 22, 23]. This perhaps reflects the challenging nature of assigning functional 
homologues using high-throughput bioinformatics pipelines, and highlights the need for 
caution when interpreting an apparent absence of genes from a given genome.   
 
2.2 Membrane topology of the CydDC complex 
A hydrophobicity analysis of the CydD (65 kDa) and CydC (63 kDa) proteins predicted that 
both subunits would have six transmembrane helices, with the C-terminal half of each 
polypeptide being hydrophilic and containing an ATP binding site [12]: this study was the 
first to recognise that CydDC was a likely ABC transporter. A significant proportion (c. 5%) 
of the E. coli genome has been reported to be occupied by ABC transporters, which have 
been categorised into 10 subfamilies [24]. This phylogenetic study placed CydD and CydC in 
group 6, along with the homodimeric MsbA lipid flippase involved in membrane biogenesis 
[25, 26]. A subsequent study presented a membrane topology model for CydDC, which 
predicted both subunits to be quite similar with six transmembrane regions separated by two 
major cytoplasmic loops, and both ends of each polypeptide chain were suggested to be 
located in the cytoplasm [27]. Topography modelling in the current review is consistent with 
this previous work, and has been used to highlight the Walker A motif that binds ATP, the 
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Walker B motif that interacts with magnesium, and a conserved histidine, glutamine, and 
aspartic acid that are part of the H-loop, Q-loop, and D-loop, respectively (Figure 1). 
 
2.3 Regulation of cydDC genes 
It is well known that the structural genes for ABC transporters and terminal oxidases in most 
bacteria are subject to strict and complex regulation at the transcriptional level [28, 29]. The 
regulation of cydDC was therefore investigated using a chromosomal (cydD-lacZ) fusion 
[30]. The operon is transcribed as a polycistronic message from a single transcriptional start 
site, independently of the upstream trxB. Transcription was independent of the carbon source 
for growth under aerobic conditions but declined as the oxygen transfer to the culture 
decreased. This is the converse of the well-known elevation of cydAB expression at lowered 
oxygen availability [28], an observation that is rationalised by the high oxygen affinity of the 
CydAB oxidase [31]. Anaerobic levels of (cydD-lacZ) fusion activity were lower and 
independent of Arc and FNR, the major regulators of cydAB expression. However, the 
inclusion in medium of anoxic electron acceptors (nitrite, nitrate, fumarate) elevated cydDC 
transcription in a manner dependent on FNR and NarL.  
Other studies have given apparently conflicting data: gene expression profiling 
showed a c. 2-fold increase under anoxic conditions in an fnr mutant [32] and potential FNR-
binding sites were recognised in the promoter region of cydDC [30, 32]. However, we 
suggested that FNR repression is indirect and mediated at the post-transcriptional level [30]. 
In agreement with this view, Boysen et al. [33] showed a marked decrease in the 5′-end 
portion of cydD mRNA on short-term induction of FnrS expression (c. 3-fold). Thus 
transcription of the cydDC operon of E. coli is negatively regulated, albeit modestly, by FnrS 
and cydDC mRNA is a direct target of FnrS [33]. 
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 Structural genes encoding bd-type oxidases and the cydDC genes encoding the ABC 
transporter have been identified in numerous other bacteria but the regulation of the cydDC 
operon has rarely been described. In Shewanella violacea, the bd-type oxidase is evident in 
difference spectra but only in cells grown under high hydrostatic pressure, although cydAB 
was expressed at all pressures tested. In contrast, cydC is depressed at atmospheric pressures 
but up-regulated strongly by high hydrostatic pressures [34]. The nucleotide sequence 
upstream of cydDC was described in further detail and putative binding sites for the NarL 
protein (which is part of a two-component regulatory system also containing the sensor 
protein NarX) were found [35]. In Brucella suis, another bacterium in which four cyd genes 
constitute a single operon, bd-type oxidase expression was not detected under aerobic 
conditions, although a slight induction was observed under microaerobiosis. At both oxygen 
concentrations, disruption of fnrN increased cydDCAB transcription levels. These results 
indicate that in contrast to the cytochrome cbb3-type oxidase in this organism, a bd-type 
oxidase is poorly expressed in vitro under microaerobic conditions and that fnrN regulator 
represses its expression [36].  
 In Mycobacterium smegmatis, cydAB and cydDC constitute two separate operons. 
Although cydAB is regulated by CRP and mutation of the identified CRP site abolishes cydA-
lacZ expression in response to hypoxia, regulation of cydDC is CRP-independent and its 
regulation is not understood [37]. Also, all cyd genes in Lactobacillus lactis, which are 
required for the organism’s haem-induced respiration-dependent mode of growth, appear to 
lack specific patterns of regulation [38]. 
 
2.4 Roles for CydDC in cytochrome assembly and haem metabolism 
The expression of CydDC is clearly linked to the incorporation of haem cofactors into a 
variety of periplasmic cytochromes as well as the bd-type respiratory oxidases. Early genetic 
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studies and biochemical studies on cydC (Section 2.1) revealed that a cydC strain and its 
isogenic parent were each capable of catalysing the in vitro synthesis of the subunits encoded 
by cydAB genes encoding cytochrome bd-I. However, the levels of subunits I and II in 
membranes from a cydC strain were very low and no incorporation of the subunit into the 
membrane was observed in a hemA mutant unable to synthesise haem [5]. These low levels of 
subunits were unexpected given earlier work with a hemA mutant in which apocytochromes 
are incorporated into the membrane [39, 40]. It appeared that the CydAB subunits were 
absent when protoporphyrin IX synthesis is blocked. This issue was re-examined by Williams 
[41] who showed that subunit I of CydAB is clearly present after immunoblotting membranes 
from both a cydD mutant and its parent, albeit at slightly lower levels in the former. They 
also demonstrated that a cydD mutation did not prevent expression from a cydA-lacZ fusion, 
showing that CydDC is not obligatory for expression of the structural genes.  
A possible role for CydDC is in haem d biosynthesis. Indeed, it has previously been 
suggested that export of the redox-active CydDC substrates may be required for the 
formation of the chlorin cofactor (i.e. haem d) in bd-type cytochromes [5, 42]. It is not known 
how the d-type haem in cytochrome bd-I is synthesised, although using hydroperoxidase 
catalase II from E. coli as a model it is likely to involve the oxidation of haem b to an 
oxoferryl species (FeIV=O) and formation of a porphyrin radical (compound I), followed by 
reduction to a ferric haem, hydroxylation of the C-ring, and cyclisation of the adjoining 
propionate [43].  It is conceivable that reducing power from GSH or cysteine may contribute 
to this process, although in the absence of insights into any enzymatic or autocatalytic 
mechanisms for incorporation of haem d into cytochrome bd-I it would be premature to 
speculate further on this topic.  
Other links with haem metabolism and processing have, however, been established. 
First, the ATPase activity of purified CydDC is modulated by haem (see Section 3.2). 
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Second, CydD is required for assembly of periplasmic cytochrome c, as well as cytochrome 
bd in E. coli. Periplasmic fractions from anaerobically grown E. coli showed the clear 
spectral signature of cytochrome c (absorbance of the reduced form at 550 nm) in the wild-
type strain but not the isogenic cydD mutant [44]. Since thioredoxin reductase is encoded by 
a gene (trxB) adjacent to cydDC, and TrxB is required for periplasmic cytochrome c 
assembly in certain bacteria, its role in cytochrome c formation in E. coli was checked, but 
cytochrome c levels in a trxB cydD
+
 strain were at wild-type levels [44]. Finally, cytochrome 
b562 is not assembled in a cydD mutant [45]. 
Given the finding that both cytochromes bd and c are affected in a cydD mutant, a 
reasonable hypothesis is that the CydDC transporter might be involved in export of haems to 
the periplasm or outer membrane face. Transmembrane haem movements are likely to be 
slow in the absence of a transporter [46] but direct measurements of haem transport are 
frustrated by the self-aggregation of haem and non-specific interactions with cell 
components. We [47] used [
14
C] haemin solubilised in alkali and in the presence of bovine 
serum albumin (BSA) as a high-affinity carrier. Since sequence homologies suggest that 
CydDC is an exporter in the intact cell, everted, energised membranes were used, which were 
hypothesised to take up haemin in vitro. In membranes from both cydD and wild-type strains, 
uptake of haemin (or its binding to membrane vesicles) were independent of the presence of 
ATP or an energising substrate (lactate) and thus do not support an ABC-driven uptake 
mechanism in cells. Chase experiments with unlabelled haemin-BSA failed to displace label 
suggesting that the labelled haem was either specifically bound to membrane protein or had 
entered the lumen of the vesicle [47]. 
During attempts to clone cydDC, candidate plasmids were assessed for their ability to 
restore assembly of a bd-type oxidase in a cydD mutant, and a variability in the effectiveness 
of the cloned genes to restore wild type oxidase levels was noted [12]. Moreover, in addition 
11 
 
to the elevated levels of cytochrome d, we noted an unusual and distinctive absorbance signal 
that appeared as a shoulder to the 560 nm peak of the b-type cytochromes. This species was 
variable in level and unstable. This component (‘P-574’ named for the visible absorbance 
maximum) was more evident in anaerobically grown cells, rendered cells reddish in colour, 
suggestive of the formation of haem compound(s), and was formed even when bd-type 
oxidase assembly was abolished by cydAB mutations [48]. The lability of P-574 was 
exploited to determine its spectrum in the absence of other stable haem compounds. The 
freeze-thaw-labile P-574 had distinctive maxima at 574 and 448 nm in reduced minus 
oxidised difference spectra. Despite showing that P-574 formation is dependent upon haem 
synthesis, its chemical nature and significance for CydDC function remain unclear [48]. The 
identity of P-574 remains unclear, but one possibility is that it represents the association of 
haem with over-expressed CydDC subunits, but not oxidase subunits. 
This proposal has an interesting parallel with assembly of certain nitrous oxide 
reductase (Nos proteins) in bacteria such as Paracoccus denitrificans. Here, a tricistronic 
nosD, -F, -Y gene arrangement is thought to encode an ABC transporter complex. NosD is 
transported by the Sec system and NosD-L fusion proteins have been reported [49]. It is 
speculated that NosD acts as a scaffold for copper centre assembly, dependent on keeping the 
copper atom in a reduced state [50]. Might CydDC act as a scaffold for haem d or 
cytochrome bd-I assembly?  
In summary, it seems likely that cytoplasmic ATP hydrolysis is used to drive an 
unknown periplasmic process, similar to the essential role of the Ccm complex in periplasmic 






3. Reductant export, kinetic modulation, and structural insights  
 
3.1 Export of reduced glutathione and cysteine by CydDC 
The demonstration that the periplasm of an E. coli cydDC knockout mutant is over-oxidising 
[45] provided the first robust evidence that this complex exported reductants. This finding 
was recently verified by demonstrating that loss of CydDC diminished the extracytoplasmic 
thiol content, and overexpression of CydDC decreased the reduced thiol pool in the 
cytoplasm [52]. These observations complemented earlier in vitro studies that demonstrated 
CydDC-mediated export of cysteine via import of 
35
S-labelled cysteine into everted 
membrane vesicles prepared from wild type and cydDC E. coli strains [53]. Addition of the 
ATP transition state analogue sodium orthovanadate abolished transport of cysteine [53], 
providing good evidence that this process was energy dependent. Note that E. coli possesses 
other L-Cys exporters; an inducible L-Cys/L-Cys shuttle system plays an important part in 
oxidative stress tolerance through provision of a reducing equivalent to the periplasm [54]. 
Since substrate promiscuity is a well-known phenomenon amongst ABC transporters, 
it was hypothesised that CydDC might also transport the tripeptide glutathione (L-γ-
glutamylcysteinylglycine, GSH), a major regulator of cellular redox poise [55]. Uptake of 
[
35
S]-labelled GSH into everted membrane vesicles was shown to be dependent upon both 
CydDC and ATP, confirming this tripeptide as a substrate for CydDC. The transport rate for 
GSH by CydDC was five-fold higher than that of cysteine and, given the abundance of GSH 
in the bacterial cytoplasm, it is likely that GSH is the main substrate for CydDC. Later work 
reported that the addition of GSH and cysteine both stimulated the ATPase activity of 
purified CydDC [56], further supporting a role in reductant export. However, while robust 
evidence exists for GSH as a CydDC substrate, other data point to the complexity of the 
process. Eser (ref 42) examined the effects of mutating cydD, ggt (encoding periplasmic -
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glutamyl transpeptidase) and mdhA (encoding a multidrug resistant-like ABC transporter) 
that might influence the concentration of periplasmic GSH pools. However, none of these 
mutations affected the ability of glutaredoxin 3 (GrxCp) to promote disulfide bond formation 
[57]. These data suggest the existence of more than one route for GSH export in E. coli. 
Several studies link transmembrane GSH fluxes with extracellular oxidative stress. 
GSH efflux from E. coli is promoted by extracellular superoxide anion but this process is not 
dependent on CydDC [58]. Note that GSH plays crucial roles in oxidative stress protection 
[59] and so the export of this compound by CydDC is of interest. 
 
3.2 Modulation of ATPase kinetics by reductants and haem 
Over two decades ago, cydDC strains of E. coli were shown to accumulate a novel haem 
compound P-574 in the periplasm and membrane fractions [48] (Section 2.4). Together with 
the previously identified role in haem incorporation into cytochrome bd-I [5], this suggested 
that haem might be a substrate for CydDC export, although later experiments with everted 
vesicles could not demonstrate a haem export function for CydDC [47]. Later work 
subsequently showed that purified CydDC displayed an absorption peak at 410-412nm, and 
pyridine haemochrome analyses indicated the presence of a bound b-type haem with a 
CydDC:haem ratio of 5:1 [56]. This bound haem could be reduced and oxidised, and a CO 
ligand was shown to bind to the reduced CydDC:haem complex. Addition of both haemin 
and GSH/cysteine had synergistic stimulatory effects upon the ATPase activity of the 
complex, indicating a functional role for the haem cofactor. The purified CydDC complex 
showed a basal ATPase activity of 100 nmol Pi/min/mg protein, and addition of GSH and 
cysteine elicited a 3-4-fold increase in activity. The addition of up to 1 µM haemin elicited a 
4-fold increase in ATPase rate, and co-incubation of 1 µM haemin and 5 mM GSH, for 
example, produced a synergistic rate stimulation of 8-fold. 
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In addition to GSH and cysteine, a variety of reduced thiol compounds were also 
shown to activate CydDC ATPase activity, including DTT, β-mercaptoethanol, 
homocysteine, and methionine. Control experiments with S-substituted/non-thiol analogues 
and protoporphyrin (i.e. haem lacking the central iron) did not elicit rate stimulation, and 
inclusion of non-thiol reductants actually decreased the ATPase rate. This strongly suggested 
the need for thiol groups or an iron-containing tetrapyrrole for rate stimulation to occur. One 
intriguing exception to this was that histidine elicited a 2-fold increase in ATPase rate, which 
was elevated to an eight-fold rate enhancement by inclusion of 1 µM haemin. Given that both 
histidine and reduced thiol compounds can act as axial ligands to haem, this might suggest 
that the haem-ligating capacity of reduced thiols is a contributory factor to the rate 
enhancements observed for GSH and cysteine in Yamashita et al [56]. 
 
3.3 Structural investigations into the CydDC complex 
The CydDC complex was first purified in 2014 using a DDM-solubilisation approach to 
solubilise his-tagged CydDC for subsequent affinity chromatography [56]. This provided the 
purified sample that enabled the identification of bound haem (Section 3.2), with the purified 
protein having a deep brown colour. Subsequent gel-filtration of this sample resolved two 
main oligomeric states, with a larger complex eluting with a 26:1 ratio of CydDC:haem, and 
a smaller complex with a 5:1 ratio of CydDC:haem. This suggests that haem binding causes a 
disaggregation of CydDC. 
 Purified CydDC was reconstituted into E. coli lipids and two dimensional crystals 
were obtained for cryo-electron microscopy (cryo-EM) analyses. This work revealed arrays 
of dimeric units in ‘up’ and ‘down’ orientations, reflecting electron densities of CydDC 
heterodimers in the crystal lattice. With regard to the native oligomeric state in the 
membrane, it is worth considering that CydDC may associate with other membrane 
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complexes. Indeed, a study on Francisella tularensis membranes has reported that the CydC 
subunit co-migrates with the CydA and CydB subunits of cytochrome bd-I using Blue Native 
SDS-PAGE [60], and the authors suggest that this provides evidence to support the existence 
of a 235 kDa CydABCD complex. This remains the only evidence for such a complex, and 
biochemical and structural work in this area will hopefully reveal further insights. While 
cryo-EM and Blue Native PAGE have provided useful insights into the overall structure of 
the CydDC complex and potential interaction partners, a crystal structure remains elusive, so 
herein we call upon structural modelling approaches to discuss the role of individual residues 
in catalysis and cofactor binding. 
Early random mutagenesis studies on cytochrome bd-I yielded the first mutant allele 
of CydD, named cydD1, that was suggested to be non-functional due to an inability to 
support the assembly of the cytochrome bd-I respiratory oxidase [9]. The two point mutations 
in cydD1 were later identified as G319D and G429E [27], and the crystal structure of the 
lipid A flippase MsbA from Vibrio cholera [61], a close structural homologue of CydD, was 
used to provide structural insights into why mutation of residues in the Walker A and B 
motifs in CydD resulted in loss of function [27]. The G429 residue was found to be close to a 
conserved aspartate, so it was postulated that substitution for a glutamate (also positively 
charged) could cause structural disruptions in the Walker A motif. The G319 residue was 
found to be buried at the bottom of the hydrophobic pocket, and it was postulated that 
mutation of this residue may impact upon conformational changes during the catalytic cycle. 
Indeed, dramatic conformational changes are key to catalytic mechanism of ABC 
transporters, and the CydDC complex has only previously been modelled in an ‘outward 
open’ conformation [62]. Hence, it was of interest to investigate structural models for CydDC 
in different conformations. 
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The alternating access model for the transport of substrates across membranes by 
transporter complexes [63] describes a mechanism involving initial formation of a 
substrate:transporter complex, which then triggers a conformational change within the 
transporter that exposes the substrate binding site at the other side of the membrane. The 
bound substrate is then able to dissociate from the transporter complex into the second 
environment in a controlled fashion, never freely permitting substrate movement through the 
membrane, as allowed through channel proteins. It was proposed that there are three 
conformational states including ‘inwardly open’, a ‘midpoint’ whereby the binding site is 
unable to access or interact with either side of the membrane, and finally an ‘outward open’ 
state that permits substrate release from the binding pocket [64]. Hence, it was of interest to 
investigate CydDC in different conformational states using modelling approaches. 
The CydDC complex has been modelled previously [62] using the SAV1866 
multidrug ABC transporter from Staphylococcus aureus (PDBid = 2HYD, [65]) as a 
template. However, with this approach it was possible to model only an outwardly open 
conformation. Hence, in an attempt to model multiple conformations, polypeptide sequences 
for CydC and CydD were submitted to the Phyre2 server [66] for structural modelling, and an 
outward open conformation was produced using the human ABCB8 transporter (PDBid = 
5OCH, chain H) that has a slightly higher % sequence identity with CydD (23%) compared to 
2HYD (22%). The model for CydD was superposed onto chain H (of 5OCH) and the model 
for CydC was superposed onto chain G (of 5OCH), and bound ADP from the 5OCH structure 
was shown to fit into the nucleotide-binding domains (NBDs) of the CydDC model adjacent 
to the Walker A motifs (Figure 2A, left hand panel). Using a similar approach, a structural 
model for an inward-open conformation was also generated using the TM287/TM288 
transporter from Thermotoga maritima (3QF4) as a template [67] (Figure 2A, right hand 
panel). One of the most important structural questions to be asked pertains to where haem 
17 
 
may interact with CydDC. Since this bound cofactor has the spectral characteristics of a b-
type haem [56], and is therefore ligated by a histidine residue, it was of interest to identify 
potential ligands on the CydDC models. Hence, all histidine sidechains in CydDC are shown 
in Figure 2A and key residues in the periplasm and nucleotide-binding domains are labelled 
in the right-hand model. 
 It has previously been postulated that His51 on CydD may be a potential ligand for 
haem due to the periplasmic location (for a potential redox-sensing role) and the favourable 
hydrostatic environment for haem binding [62]. However, recent work in the Shepherd lab 
has demonstrated that purified CydDC H51A
CydD
 still retains a significant amount of bound 
haem [68], discounting the involvement of this residue in the axial ligation of haem. There is, 
however, another periplasmic histidine in CydD at position 284 (Figure 2A) that remains a 
potential ligand to participate in a periplasmic redox sensing role. However, the jury is still 
out on the location of haem ligation, as the full-length CydDC sequences contain 22 fully-
conserved histidine residues across the four closest homologues (E. coli, Salmonella enterica, 
Klebsiella pneumoniae, Shigella sonnei, Citrobacter portucolensis). Hence, all the histidine 
residues shown on Figure 2A are conserved and are therefore potential haem ligands, which 
will lead to an exciting mutagenesis study in future. Given the profound effects that haem 
binding has upon ATP hydrolysis [56], the location of histidine residues in the NBDs have 
been annotated in detail on Figure 2B, which may allow a productive focus in the first 




, which are part of the conserved H-
loops involved in ATP hydrolysis, the remaining histidine residues annotated in Figure 2B 
seem like plausible candidates for haem ligation.  
  




4.1 Protein disulfide folding 
It has been hypothesised that the pleiotropic phenotype of cydDC strains results largely from 
the disruption of disulfide folding in the periplasm [55]. Indeed, sensitivity of the cydDC 
mutant to benzylpenicillin was attributed to misfolding of the disulfide-containing Penicillin-
Binding Protein 4, and lack of motility was suggested to result from a defective P-ring motor 
protein (also disulfide-containing) [53], especially since exogenous addition of cystine 
(oxidised cysteine) had previously been shown to correct a motility defect in a dsbB mutant 
[69]. Complementation of cydDC strains with exogenous reductant largely complemented 
those phenotypes that are associated with defective disulfide folding [55]. 
Disulfide bond formation plays a critical role in the stability of numerous proteins, 
especially those that are secreted (for an overview, see[70]). In the bacterial periplasm, there 
are two main pathways for disulfide bond formation: disulfide oxidation and disulfide 
isomerisation. Disulfide oxidation is catalysed by the DsbAB system [71] and disulfide 
isomerisation is catalysed by the DsbCD system [72]. It has previously been hypothesised 
that reduced thiol-containing CydDC substrates can contribute to the reduction of protein 
disulfides [53, 55], and that electrons evolved during subsequent DsbAB-mediated disulfide 
oxidation can be channelled into the terminal oxidases of the respiratory chain [73]. This is 
particularly interesting as loss of CydDC function was first described to abolish the assembly 
of the terminal oxidase cytochrome bd-I [5], and exogenous addition of the CydDC-
substrates GSH and cysteine was later shown to be restore haem incorporation into 
cytochrome bd-I in a cydD strain [52]. Together, these observations indicate that CydDC-
mediated respiratory oxidase assembly can provide an electron sink for Dsb-mediated 
disulfide oxidation, and the CydDC substrates GSH and cysteine may also have a more direct 




4.2 Roles of CydDC and cytochrome bd in virulence  
Since cydDC mutants do not synthesise cytochrome bd, and both cydDC and cydAB mutants 
display diverse and sometimes overlapping phenotypes, it is important but difficult to 
differentiate between oxidase deficiency per se and the additional defects in cydDC mutants. 
These problems are discussed in [29]. Thus, while all cydAB mutants (to our knowledge) lack 
spectroscopically detectable cytochrome bd, fail to survive as robustly as wild-type cells in 
stationary phase [6, 7], and are sensitive to various inhibitors (cyanide, azide, Zn(II) ions) and 
oxidative stress, cydDC mutants additionally show low levels of other cytochromes, 
particularly periplasmic haemproteins, and have a more oxidised periplasm.  
As discussed in Section 3.1, cydDC mutants fail to export glutathione and cysteine to 
the periplasm and this results in a more oxidised periplasm. However, what is not clear is 
why bd-type oxidase assembly is inhibited by these defects. Among plausible hypotheses are 
the following: 
 CydDC exports to the periplasm haem(s) to be immediately assembled onto outward-
facing CydAB subunit regions (although we have failed to detect bulk transmembrane 
movements of haem; [47]). However, the finding that haem stimulates the ATPase activity 
of purified CydDC as well as reductants is intriguing (Section 3.2). 
 CydDC positions haems at periplasmic sites such as chaperones for oxidase assembly. 
 The oxidised periplasm is incompatible with haem-handling and –assembling processes. 
 CydDC exports to the periplasm components thus far unidentified, in addition to the 
reductants glutathione and cysteine. 
It has been frequently reported that the presence of bd-type oxidases is correlated with 
bacterial virulence. For example, growth of Mycobacterium sp. at low oxygen tensions 
thought to enhance expression of a bd-type oxidase also enhances invasion [75]. Furthermore, 
a positive correlation has been shown between bd-type oxidase expression and Shigella 
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flexneri virulence [76]. Because cydDC mutants share all phenotypes of cydAB mutants, but 
have additional defects, the abrogation of bacterial virulence and pathogenicity evident in 
cydAB mutants would be expected to be shared by cydDC mutants, although this has been 
less frequently tested. Mutations in aarD, a cydD homologue in Providencia stuartii, caused 
a 32-fold increase in resistance to gentamycin [77]. Interestingly, mutations in aarE, a ubiA 
homologue and thus involved in respiratory ubiquinone biosynthesis, also led to high-level 
aminoglycoside resistance [78] consistent with the requirement for respiratory chain function 
in aminoglycoside uptake [79]. A Brucella abortus cydC mutant created by a Tn5 transposon 
insertion was virtually incapable of intracellular replication in murine macrophages and a 
HeLa cell line and also exhibited impaired virulence in BALB/c mice [80]. A further study of 
a virulent strain used unmarked knockout mutants in cydD and cydC. Mutation in either gene 
caused sensitivity to metal ions, oxidative stress and low pH and, significantly, a growth 
defect in RAW264.7 cells and attenuation in mice [81]. Both cydC and cydD mutants 
exhibited significant attenuation of virulence when assayed in murine macrophages or in 
BALB/c mice and were readily cleared from spleens by 4 weeks post-inoculation. Inoculated 
mice showed no splenomegaly, which indicates that the mutants are highly attenuated [82]. In 
contrast, a cydC mutant of Moraxella catarrhalis, while being defective in growth rates and 
oxidative stress tolerance, did not display a difference in a murine pulmonary clearance 
model . The mutation in the mutant studied may however merely alter transcription levels of 
cydC [83].  
 
4.3 Perturbations resulting from loss of CydDC 
The loss of a functional CydDC transporter yields a pleiotropic phenotype, including loss of 
haem insertion in bd-type cytochromes as described earlier [5, 9, 41], and periplasmic 
cytochromes c and b562 are also less abundant in cydDC mutants [44, 45]. In addition, the 
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periplasm of cells lacking CydDC were found to be over-oxidised [8], consistent with a later 
study where CydDC overexpression diminished the cytoplasmic reduced thiol content [52], 
although the cytoplasm of cells lacking CydDC were not ‘over-reducing’. Strains lacking 
CydDC have also been shown to exhibit sensitivity to benzylpenicillin and loss of motility 
[53], which was hypothesised to be due to defective disulfide folding of penicillin binding 
protein 4 and the P-ring flagellar protein, respectively.  
To further characterise the pleiotropic cydDC phenotype, transcriptomics was used to 
demonstrate a dramatic up-regulation of a range of transcripts in a cydD strain involved in 
protein degradation pathways, protein chaperones, β-oxidation of fatty acids, and transcripts 
involved in nitrate/nitrite reduction [52]. The upregulation of protein degradation pathways 
and fatty acid β-oxidation were proposed to be involved in the re-balancing of metabolic flux 
into the Krebs cycle through elevation of succinyl CoA and pyruvate production, 
respectively. The up-regulation of nitrate reductase nap genes in the cydD strain was also 
interesting, as these systems are usually induced only during anaerobic conditions. However, 
the expression of CydDC has previously been shown to be induced by nitrate/nitrate under 
the control of the transcription factors NarL, NarP, and FNR [30], and in a cydD mutant that 
cannot assemble bd-type oxidases it seems logical that the Nap system is up-regulated to 
compensate for an inability to oxidise reduced ubiquinol via bd-type respiratory oxidases. 
 
4.4 Tolerance to nitric oxide 
CydDC has recently been shown to protect E. coli against nitric oxide (NO) [52], a toxic free 
radical produced by the host immune system in response to bacterial infection. Since CydDC 
expression is required for the assembly of cytochrome bd-I [5, 9], which was known to 
promote growth and survival in the presence of NO [52, 84], it was anticipated that CydDC 
expression would promote NO tolerance indirectly via facilitating cytochrome bd-I assembly. 
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In addition, as the reduced thiols that are exported by CydDC may react with incoming NO 
(to form S-nitrosothiols), it was hypothesised that CydDC would provide protection from NO 
beyond the involvement of cytochrome bd-I. This hypothesis was tested via growth of 
knockout strains in the presence of NO-donor compounds, and CydDC was confirmed to 
provide protection against NO beyond the contribution to assembly of cytochrome bd-I. This 
has led to the generation of a model for the role of CydDC in NO tolerance, as well as 
disulphide folding and respiratory oxidase assembly (Figure 3). These insights highlight the 
potential importance of CydDC-mediated reductant export in stress tolerance of pathogenic 
E. coli strains during infection. 
 
5. Conclusions 
The CydDC ABC-type transporter of Escherichia coli was the first heterodimeric exporter of this 
class to be described in prokaryotes. The cydDC genes are widely distributed in bacteria but their 
precise functions are still unresolved. The genes are sometimes found in an operon with cydABX that 
encodes a bd-type terminal oxidase and this, coupled with the loss of bd-type oxidase assembly and 
function in CydDC mutants, identifies CydDC as crucial to this respiratory complex. Current 
hypotheses favour the view that the CydDC system transports reducing molecules to the periplasm, 
notably glutathione and cysteine; these, together with other reduced thiol compounds, also stimulate 
the ATPase activity of the isolated CydDC complex. We lack unambiguous evidence that CydDC 
may transport haem outwards for periplasmic cytochrome assembly, but there are tantalising clues to 
suggest a direct involvement of haem with CydDC function. Given the importance of cytochrome bd-I 
assembly, and of direct CydDC-catalysed reactions with nitric oxide, for bacterial virulence and 
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Figure 1 – Membrane topology modelling for CydD and CydC. 
Membrane topology models for CydD (A) and CydC (B) were produced using the Protter 
online tool [85]. Transmembrane helices are numbered sequentially with Roman numerals, 
and the conserved motifs in the nucleotide-binding domains are colour coded and annotated 
on the figure. 
Figure 2 – Structural modelling of the CydDC complex. 
Polypeptide sequences for CydC and CydD were submitted to the Phyre2 server [66], and a 
structural model in an ‘outward open’ conformation (left hand side) was produced using the 
human ABCB8 transporter (PDBid = 5OCH, chain H) as a template. Using a similar 
approach, a structural model for an ‘inward-open’ conformation was also generated using the 
TM287/TM288 transporter from Thermotoga maritima (3QF4) as a template [67] (right hand 
side). All histidine sidechains are shown (they are potential ligands to haem – shown in centre 
of the figure panel) and key residues in the periplasm and nucleotide-binding domains are 
labelled in the right-hand panel. Bound ADP is shown as spheres and Walker A motifs are 
shown in red. B) The nucleotide-binding domain of the inward open model from panel A is 
shown, with conserved motifs highlighted in colour and annotated in the key. Abbreviations: 
ICLs, intracytoplasmic loops; NBDs, nucleotide-binding domains; TMDs, transmembrane 
domains. 
Figure 3 – Model for the multiple roles for the CydDC complex. 
CydDC activity is required for cofactor assembly in bd-type oxidases (red), which is probably 
mediated by the reduced substrates (GHS and cycteine) as their exogenous addition can 
restore bd-type oxidase assembly [52], although  direct delivery of haem from CydDC cannot 
yet be ruled out (red dashed line). Haem cofactors are shown as red rhomboids with black 
dots. CydDC provides additional protection against NO beyond that provided by cytochrome 
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bd-I, and it is hypothesised that the reduced substrates form S-nitroso adducts (R-S-N=O) that 
sequester NO and diminish entry into the cytoplasm (blue). It is hypothesised that the reduced 
substrates may control gating of the CydDC complex through reduction of bound haem 
cofactors (cyan). Finally, has been hypothesised that CydDC provides a role in disulphide 
assembly [53] (purple), chiefly because loss of cydDC genes affects phenotypes that rely 
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